GreensKeeper Asset Management, an investment management firm, released its Q3 2025 investor letter. A copy of the letter can be downloaded here. The Value Fund ended the quarter with a gain of +4.0%, bringing year-to-date performance to +0.2% net of fees and expenses. The US dollar continued to pose a challenge, negatively impacting performance by -3.7% year-to-date. This year’s market rally was mainly led by artificial intelligence, cryptocurrencies, and speculation. Additionally, you can check out the fund’s top five holdings to determine your best picks for 2025.
In its Q3 2025 investor letter, GreensKeeper Asset Management highlighted stocks like Novo Nordisk A/S (NYSE:NVO). Novo Nordisk A/S (NYSE:NVO) is engaged in the research and development, manufacturing and distribution of pharmaceutical products. Novo Nordisk A/S (NYSE:NVO)’s monthly performance was -0.08% and its stock lost 53.79% of its value in the last 52 weeks. On December 16, 2025, Novo Nordisk A/S (NYSE:NVO) stock closed at $48.96 per share, with a market capitalization of $217.553 million.
GreensKeeper Asset Management stated the following regarding Novo Nordisk A/S (NYSE:NVO) in its Q3 2025 investor letter:
“Our second biggest detractor in the quarter was Novo Nordisk A/S (NYSE:NVO) -19.6%. NVO lowered its guidance due to several factors, including persistent use of GLP-1 compound drugs, slower-than-expected market expansion for obesity treatments, and increased competition from Eli-Lilly’s tirzepatide-based therapies. We welcome the recently announced changes in senior management and the company’s new focus on operational efficiency.
Novo Nordisk A/S (NYSE:NVO) isn’t on our list of the 30 most popular stocks among hedge funds. According to our database, 50 hedge fund portfolios held Novo Nordisk A/S (NYSE:NVO) at the end of the third quarter, up from 45 in the previous quarter. While we recognize the potential of Novo Nordisk A/S (NYSE:NVO) as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.